CCC mentioned in the media: “Brewers put money into ‘drugs’”
Harry van Gelder, 5th of September, 2018
De Telegraaf
Beer brewers are investing more frequently in the booming cannabis market. Last month, Constellations Brands, makers of Corona beer, announced almost $4 billion in investments in Canopy Growth, Canada’s largest cannabis firm. Molson Coors are by now working together with medicinal cannabis producers Hydropothecary. Heineken, too, are putting up some show in this field.
In California, American subsidiary Lagunitas are marketing the Hi-Fi Hops cannabis drink. It boils down to a sparkling hop water, infused with the cannabis substance THC. Where top executive Jean Francois van Boxmeer got more than just a shock on hearing about the plans (“Have you gone completely mad?”), he has by now become convinced of the appropriateness of this step, which is legitimate by the way. Lagunitas are allowed free range as long as this does not invoke legal problems.
This consent on the part of Van Boxmeer might well turn out to be a good decision. After all, despite president’s Trump’s war on drugs, interest on the part of Wall Street in investing in marijuana firms just never was as high as this. According to Bloomberg, the North-American Marijuana index rose by 140% this year; a poor contrast being the S&P 500, at a mere 17%.
This year, legitimate cannabis sales in the US are moving around $6 billion. According to analysts at Canadian investment bank GMP Securities, the American market will be valued at over $20 billion by 2022.
How CBD has become the USA’s coolest food and drink ingredient
(CNN) — The latest "it" ingredient to hit menus is [...]
Prohibition Partners Presentation
Stephen Murphy - Prohibition Partners [...]
Bedrocan Presentation
Tjalling Erkelens & Mauricio Agudelo - Bedrocan [...]
Phytonext/Cannabis Industry Europe Presentation
Juriën Koster - Phytonext/Cannabis Industry Europe [...]
Canaccord Presentation
Alex Brooks - Canaccord
Palo Verde Presentation
R Gary Mesch - Palo Verde Global [...]
Investment: the emerging cannabis market
The Cannabis Capital Convention is the first cannabis conference in the Netherlands for investors and entrepreneurs.
According to The Cannabis Industry 2017 Annual Report, sales of cannabis – both recreational and medical – will take off in 2018 with an expected reach of $4.75 billion. In 2025, the forecast is that it will hit $25 billion. This is a result of the legalization of cannabis for recreational use in Canada as well as multiple states in the United States of America. The legalization is expected to extend to other states as well, after the mid-term elections this November. When more states and countries legalize the production and consumption of this product, even more new businesses will appear, something that we have already seen in the last years. In North America cannabis has been recognized as a profitable emerging market, which caused multiple companies and funds to arise, which are invested in on a big scale.
In Europe, the cannabis market is emerging as well. In the last half year, the cannabis industry in Europe has grown more than in the last five years. Multiple European countries have announced legislation and millions of dollars have been invested in the European cannabis industry alone. Europe has benefitted from the abovementioned global developments, since the governments can follow the lead of North America. Governments now fully comprehend the benefits that come with the legislation of cannabis, socially as well as financially.
We want to bring the knowledge of the North American cannabis investors and the newness of the European cannabis market together in our Cannabis Capital Convention. Here, experienced experts from cannabis production companies, investors and analysts are invited as speakers and this will help in the investor learning experience. Also, European experts are invited to tell you about the current trends in this relatively unknown investment market.
The goal of the Cannabis Capital Convention is to inform about the investing opportunities in the cannabis industry. Speakers range from product specialists and companies to analysts from leading investment banks in cannabis. The day is filled with instructive speeches aspired to give you insights into these investment opportunities and to network with cannabis investors and influencers during lunch and drinks. An overview of the day:
We are proud to announce that the convention will be held at the memorable location of Eye Filmmuseum Amsterdam, which is located in the center of the capital, across the Central Station. Apart from an atmospheric venue for events, the Eye is a film museum dedicated to cinematography. The location is known for its architecture, designed by Roman Delugan and Elke Delugan-Meissl, opened in 2012. The venue has a capacity of 300, which will cause it to be an exclusive occasion. There will be a lot of room for networking with the participants as well as with the speakers.
Since 2003 Bedrocan provides standardised cannabis of pharmaceutical quality to the Dutch government. It’s the oldest legal company in the world providing several, chemically different cannabis varieties to be used by patients on doctor’s prescription and as a raw material for the pharmaceutical industry (API).
For the past 20 years, Tjalling has developed and standardised unique methods of producing cannabis to pharmaceutical standards to a level achieved by no other company.
world specializing in finance and cannabis, including China, Europe, and North America.
The program will be updated, if you would like to stay informed about the upcoming speakers then you can register to our newsletter.
Contact
For more information about the programming, please subscribe to our newsletter.
If you have any other questions or remarks, feel free to email us: info@cannabiscapitalconvention.eu